To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says

 
• By Sarah Karlin-Smith
  
HHS Secretary Robert F. Kennedy Jr., CMS Administrator Mehmet Oz and NIH Director Jay Bhattacharya spoke at the FDA's 5 June cell and gene therapy panel. (Derrick Gingery)

More from Cell & Gene Therapies

More from Rare Diseases